We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned.
- Authors
Hayne, Dickon; Stockler, Martin; McCombie, Steve P.; Lawrence, Nicola; Martin, Andrew; Sengupta, Shomik; Davis, Ian D.
- Abstract
The article discusses the authors' views on the progress report of BCG + Mitomycin trial for the treatment of high-risk non-muscle-invasive bladder cancer in Australia. They present a meta-analysis which suggested reduced progression and recurrence rates with combination treatment. The authors explain the outcomes of the randomized trial to clarify the effects of treatment dosage and length of maintenance for BCG.
- Subjects
BCG immunotherapy; MITOMYCINS; BLADDER cancer treatment; COMBINATION drug therapy; BLADDER cancer; RANDOMIZED controlled trials; TREATMENT effectiveness; THERAPEUTICS
- Publication
BJU International, 2017, Vol 119, p55
- ISSN
1464-4096
- Publication type
Article
- DOI
10.1111/bju.13873